Cambridge Financial Group Inc. Acquires 493 Shares of Humana Inc. (NYSE:HUM)

Cambridge Financial Group Inc. raised its holdings in Humana Inc. (NYSE:HUM) by 4.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,488 shares of the insurance provider’s stock after purchasing an additional 493 shares during the quarter. Humana accounts for 2.6% of Cambridge Financial Group Inc.’s investment portfolio, making the stock its 27th largest position. Cambridge Financial Group Inc.’s holdings in Humana were worth $5,259,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Dorsey & Whitney Trust CO LLC boosted its holdings in shares of Humana by 2.6% in the 3rd quarter. Dorsey & Whitney Trust CO LLC now owns 817 shares of the insurance provider’s stock worth $397,000 after buying an additional 21 shares during the last quarter. First Financial Corp IN grew its position in shares of Humana by 7.2% during the 4th quarter. First Financial Corp IN now owns 343 shares of the insurance provider’s stock valued at $157,000 after acquiring an additional 23 shares during the period. First Trust Direct Indexing L.P. grew its position in shares of Humana by 0.8% during the 3rd quarter. First Trust Direct Indexing L.P. now owns 2,926 shares of the insurance provider’s stock valued at $1,424,000 after acquiring an additional 24 shares during the period. Nvwm LLC increased its stake in shares of Humana by 41.0% during the 3rd quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock worth $42,000 after purchasing an additional 25 shares during the last quarter. Finally, Community Bank & Trust Waco Texas raised its holdings in shares of Humana by 3.7% in the 3rd quarter. Community Bank & Trust Waco Texas now owns 841 shares of the insurance provider’s stock worth $408,000 after purchasing an additional 30 shares during the period. Institutional investors own 92.38% of the company’s stock.

Insider Buying and Selling at Humana

In related news, Director Jorge S. Mesquita purchased 545 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The stock was bought at an average cost of $367.09 per share, with a total value of $200,064.05. Following the completion of the purchase, the director now directly owns 2,578 shares in the company, valued at $946,358.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.32% of the company’s stock.

Humana Price Performance

NYSE:HUM traded down $0.44 during mid-day trading on Friday, reaching $320.54. The stock had a trading volume of 1,802,675 shares, compared to its average volume of 1,607,966. Humana Inc. has a one year low of $298.61 and a one year high of $541.21. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 1.67. The firm has a 50 day moving average price of $324.12 and a two-hundred day moving average price of $387.61. The stock has a market capitalization of $38.63 billion, a P/E ratio of 19.96, a P/E/G ratio of 1.86 and a beta of 0.49.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, beating the consensus estimate of $6.12 by $1.11. The company had revenue of $29.61 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The firm’s quarterly revenue was up 10.7% compared to the same quarter last year. During the same quarter last year, the firm earned $9.38 EPS. As a group, analysts expect that Humana Inc. will post 16.18 earnings per share for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.10%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio (DPR) is currently 22.04%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on HUM. Jefferies Financial Group lowered their target price on Humana from $411.00 to $381.00 and set a “buy” rating on the stock in a research note on Monday, April 22nd. TD Cowen cut their target price on shares of Humana from $427.00 to $396.00 and set a “buy” rating for the company in a research report on Tuesday, April 2nd. StockNews.com lowered shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 26th. Barclays cut their price objective on shares of Humana from $356.00 to $310.00 and set an “equal weight” rating for the company in a report on Tuesday, April 2nd. Finally, Wells Fargo & Company lowered their target price on shares of Humana from $413.00 to $350.00 and set an “overweight” rating on the stock in a report on Monday, April 8th. Eleven equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $424.50.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.